Journal of Commercial Biotechnology

Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers

Laura Heinonen — June 24, 2008

Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers

Journal of Commercial Biotechnology advance online publication, June 24, 2008. doi:10.1057/jcb.2008.25

Authors: Laura Heinonen & Birgitta Sandberg

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies

Arlen D Meyers — June 17, 2008

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies

Journal of Commercial Biotechnology advance online publication, June 17, 2008. doi:10.1057/jcb.2008.22

Authors: Arlen D Meyers, Donald J McCubbrey & Richard T Watson

Got value? Determine it. Demonstrate it. Communicate it. Realise it

Mitch DeKoven — April 15, 2008

Got value? Determine it. Demonstrate it. Communicate it. Realise it

Journal of Commercial Biotechnology advance online publication, April 15, 2008. doi:10.1057/jcb.2008.7

Authors: Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg & Shibani Pokras

Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice

Kerstin M Bode-Greuel — March 4, 2008

Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice

Journal of Commercial Biotechnology advance online publication, March 4, 2008. doi:10.1057/jcb.2008.6

Authors: Kerstin M Bode-Greuel & Klaus J Nickisch